9 February 2011 - Icelandic generic pharmaceuticals company Actavis Group said on Tuesday that it has obtained approval from the US Food and Drug Administration (FDA) to market Pantoprazole Sodium
Delayed-Release Tablets, USP.
According to IMS Health, Pantoprazole Sodium
DR Tablets recorded US sales of approximately USD1.
for Injection is a gastrointestinal drug used in the treatment of gastroesophageal reflux disease (GERD) related with the history of erosive esophagitis.
Reddy's Laboratories (NYSE:RDY) reported on Thursday that the company has introduced Pantoprazole Sodium
Delayed-Released tablets (20mg and 40mg strengths) in the US market.
Sales of pantoprazole sodium
delayed-release tablets in the USA were approximately USD1.
Reddy's Laboratories (NYSE:RDY) today announced that it has launched Pantoprazole Sodium
Delayed-Released tablets (20mg and 40mg strengths), a bioequivalent generic version of Protonix[R]Tablets in the US market.
40 Pantoprazole Sodium
Torrent 13668042990 6,876,264
Tenders are invited for Clarithromycin Plus Pantoprazole Sodium
Plus Amoxycillin Kit Of 6 Tabs.
Teva's Pantoprazole Sodium
DR Tablets are the AB-rated generic equivalent of Wyeth's erosive GERD treatment Protonix[R] DR Tablets.